Mifepristone, the first pill in a medication abortion, at a clinic in Carbondale, Ill. (Evelyn Hockstein/Reuters)
Leviticus 24:17 “Whoever takes a human life shall surely be put to death.
Important Takeaways:
- There will likely be a showdown at the Supreme Court over a widely used abortion pill.
- A federal appeals court ruled yesterday that mifepristone can remain on the market, but the judges would reimpose prior restrictions that could limit access to the medication.
- This includes preventing the drug from being mailed directly to patients and changing the approved use of the pill from up to 10 weeks into pregnancy back down to seven weeks.
- This all comes as the legal battle over medication abortion has escalated over the past few months with the outcome having the potential to once again reshape the country’s abortion landscape.
- The Biden administration has already said it’s planning to fight the ruling
- Erin Hawley, an attorney for the group filing the lawsuit, said she was pleased with the court’s decision despite arguing the pill shouldn’t have been approved in the first place. Hawley, who is married to Sen. Josh Hawley (R-Mo.), said her team hasn’t decided whether to appeal the portion of the ruling that went against them.
Read the original article by clicking here.
